Published in Am J Gastroenterol on July 07, 2007
Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer (2012) 1.26
Recent Advances in Tumor Ablation for Hepatocellular Carcinoma. Liver Cancer (2015) 1.08
Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma. World J Gastroenterol (2008) 1.07
Elevated plasma IL-6 associates with increased risk of advanced fibrosis and cholangiocarcinoma in individuals infected by Opisthorchis viverrini. PLoS Negl Trop Dis (2012) 1.00
Biliary strictures: diagnostic considerations and approach. Gastroenterol Rep (Oxf) (2014) 0.99
miR-17-92 cluster promotes cholangiocarcinoma growth: evidence for PTEN as downstream target and IL-6/Stat3 as upstream activator. Am J Pathol (2014) 0.99
Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma. HPB (Oxford) (2012) 0.98
A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures. Br J Cancer (2011) 0.92
The role of photodynamic therapy for hilar cholangiocarcinoma. Korean J Intern Med (2010) 0.91
Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies. Cancer Metastasis Rev (2015) 0.89
Current status of photodynamic therapy for bile duct cancer. Clin Endosc (2013) 0.85
Targeting IL-6 in cholangiocarcinoma therapy. Am J Gastroenterol (2007) 0.85
Molecular pathogenesis of cholangiocarcinoma. Dig Dis (2014) 0.83
ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer. Sci Rep (2016) 0.82
Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma. PLoS One (2010) 0.81
A perspective on molecular therapy in cholangiocarcinoma: present status and future directions. Hepat Oncol (2014) 0.81
Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma. World J Gastroenterol (2012) 0.81
A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma. Cancer (2017) 0.81
Diagnostic and therapeutic biomarkers in pancreaticobiliary malignancy. World J Gastrointest Endosc (2016) 0.78
Novel endoscopic approaches in the diagnosis and management of biliary strictures. F1000Prime Rep (2013) 0.78
An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol (2008) 0.75
Factors predictive of adverse events following endoscopic papillary large balloon dilation: results from a multicenter series. Dig Dis Sci (2012) 4.35
An analysis of the experiences of 62 patients with moderate complications after full-face fat injection for augmentation. Plast Reconstr Surg (2012) 2.20
Impact of patient education with cartoon visual aids on the quality of bowel preparation for colonoscopy. Gastrointest Endosc (2012) 2.11
Pretarsal Augmented Lower Blepharoplasty. Plast Reconstr Surg (2016) 1.93
Endoscopic diagnosis of open-type atrophic gastritis is related to the histological diagnosis of intestinal metaplasia and Cdx2 expression. Dig Dis Sci (2011) 1.93
Overtube-balloon-assisted direct peroral cholangioscopy by using an ultra-slim upper endoscope (with videos). Gastrointest Endosc (2009) 1.88
Clinical and epidemiological features of hepatitis C virus infection in South Korea: a prospective, multicenter cohort study. J Med Virol (2013) 1.86
Primary incisional therapy with a modified method for patients with benign anastomotic esophageal stricture. Gastrointest Endosc (2009) 1.68
Newly designed stent for endoscopic bilateral stent-in-stent placement of metallic stents in patients with malignant hilar biliary strictures: multicenter prospective feasibility study (with videos). Gastrointest Endosc (2009) 1.66
Superior mesenteric artery syndrome: where do we stand today? J Gastrointest Surg (2012) 1.59
Combined endoscopic stent-in-stent placement for malignant biliary and duodenal obstruction by using a new duodenal metal stent (with videos). Gastrointest Endosc (2009) 1.59
A nationwide seroepidemiology of hepatitis C virus infection in South Korea. Liver Int (2013) 1.57
The role of intraductal US in the management of idiopathic recurrent pancreatitis without a definite cause on ERCP. Gastrointest Endosc (2011) 1.57
[Comparison of survival of advanced hilar cholangiocarcinoma after biliary drainage alone versus photodynamic therapy with external drainage]. Korean J Gastroenterol (2004) 1.56
Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma. Gastroenterology (2010) 1.55
Use of detachable snares and elastic bands for endoscopic control of bleeding from large gastric varices. Gastrointest Endosc (2002) 1.54
Effects of vardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction. Gastrointest Endosc (2009) 1.52
Usefulness of three-dimensional, multidetector row CT (virtual gastroscopy and multiplanar reconstruction) in the evaluation of gastric cancer: a comparison with conventional endoscopy, EUS, and histopathology. Gastrointest Endosc (2004) 1.51
Intraductal balloon-guided direct peroral cholangioscopy with an ultraslim upper endoscope (with videos). Gastrointest Endosc (2009) 1.50
Small sphincterotomy combined with endoscopic papillary large balloon dilation versus sphincterotomy. World J Gastroenterol (2009) 1.49
Clinical characteristics and the expression profiles of inflammatory cytokines/cytokine regulatory factors in asymptomatic patients with nodular gastritis. Dig Dis Sci (2012) 1.49
Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol (2012) 1.47
Usefulness of intraductal ultrasonography in icteric patients with highly suspected choledocholithiasis showing normal endoscopic retrograde cholangiopancreatography. Dig Dis Sci (2014) 1.47
[Efficacy of peginterferon and ribavirin combination therapy of chronic hepatitis C: a pooled analysis]. Korean J Gastroenterol (2012) 1.46
Cold snare polypectomy vs. Cold forceps polypectomy using double-biopsy technique for removal of diminutive colorectal polyps: a prospective randomized study. Am J Gastroenterol (2013) 1.46
[Clinical outcome of treatment with infliximab in Crohn's disease: a single-center experience]. Korean J Gastroenterol (2013) 1.45
Is lesion size an independent indication for endoscopic resection of biopsy-proven low-grade gastric dysplasia? Dig Dis Sci (2013) 1.45
[Efficacy of entecavir switching therapy in chronic hepatitis B patients with clevudine-induced myopathy]. Korean J Gastroenterol (2013) 1.43
Risk for coronary heart disease increases risk for colorectal neoplasm. Clin Gastroenterol Hepatol (2012) 1.43
The prevalence of elevated alanine transaminase and its possible causes in the general Korean population. J Clin Gastroenterol (2014) 1.43
Comparison of endoscopic papillary balloon dilation and sphincterotomy in young patients with CBD stones and gallstones. Dig Dis Sci (2013) 1.42
Delayed endoscopic papillary large balloon dilation after sphincterotomy for removing large bile duct stones in patients with acute cholangitis. Dig Dis Sci (2014) 1.42
Influenza A (H1N1) 2009 pandemic calm down the prevalence of acute hepatitis A in the latter half of 2009: Korean population study. Korean J Gastroenterol (2012) 1.41
Suboptimal Bowel Preparation Significantly Impairs Colonoscopic Detection of Non-polypoid Colorectal Neoplasms. Dig Dis Sci (2015) 1.41
[Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis]. Korean J Hepatol (2006) 1.41
A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus. J Hepatol (2011) 1.41
[Significance of microsatellite instability in early gastric cancer treated by endoscopic submucosal dissection]. Korean J Gastroenterol (2008) 1.40
[Clinical features of non-alcoholic fatty liver disease in cryptogenic hepatocellular carcinoma]. Korean J Gastroenterol (2014) 1.39
[Comparison of the cut direction between gross finding, streoscopic finding, and pathologic mapping of endoscopic submucosal dissection Specimen]. Korean J Gastroenterol (2010) 1.39
[Role of cyclooxygenase-2 (COX-2) and peroxisome proliferator-activated receptor (PPAR) in gastric cancer]. Korean J Gastroenterol (2004) 1.39
Imaging features of adult choledochal cysts: a pictorial review. Korean J Radiol (2009) 1.34
Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis. Surgery (2009) 1.34
Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B. Hepatology (2007) 1.33
Asia-Pacific consensus recommendations for endoscopic and interventional management of hilar cholangiocarcinoma. J Gastroenterol Hepatol (2013) 1.33
The Effect of the Bowel Preparation Status on the Risk of Missing Polyp and Adenoma during Screening Colonoscopy: A Tandem Colonoscopic Study. Clin Endosc (2012) 1.32
The detection of bile duct stones in suspected biliary pancreatitis: comparison of MRCP, ERCP, and intraductal US. Am J Gastroenterol (2005) 1.28